Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ThermoGenesis Holdings, Inc. (THMO : NSDQ)
 
 • Company Description   
ThermoGenesis Holdings Inc. develops, commercializes and markets automated technologies for CAR-T and other cell-based therapies. The company markets solutions for automated clinical biobanking, point-of-care applications and automation for immuno-oncology. ThermoGenesis Holdings Inc., formerly known as Cesca Therapeutics Inc., is based in Rancho Cordova, California.

Number of Employees: 40

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.34 Daily Weekly Monthly
20 Day Moving Average: 69,333 shares
Shares Outstanding: 12.83 (millions)
Market Capitalization: $4.43 (millions)
Beta: 2.96
52 Week High: $3.16
52 Week Low: $0.31
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -40.52% -34.87%
12 Week -46.00% -39.31%
Year To Date -65.84% -58.27%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2711 CITRUS ROAD
-
RANCHO CORDOVA,CA 95742
USA
ph: 916-858-5100
fax: 916-858-5199
ir@thermogenesis.com http://www.thermogenesis.com
 
 • General Corporate Information   
Officers
Chris Xu - Chief Executive Officer and Chairman
Haihong Zhu - Chief Operating Officer
Jeff Cauble - Chief Financial Officer
Russell Medford - Director
Joseph Thomis - Director

Peer Information
ThermoGenesis Holdings, Inc. (CORR.)
ThermoGenesis Holdings, Inc. (RSPI)
ThermoGenesis Holdings, Inc. (CGXP)
ThermoGenesis Holdings, Inc. (BGEN)
ThermoGenesis Holdings, Inc. (GTBP)
ThermoGenesis Holdings, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 88362L100
SIC: 3821
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 12.83
Most Recent Split Date: 6.00 (0.10:1)
Beta: 2.96
Market Capitalization: $4.43 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.02 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.11 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 3.14
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.21
Price/Cash Flow: -
Price / Sales: 0.42
EPS Growth
vs. Year Ago Period: 23.81%
vs. Previous Quarter: 27.27%
Sales Growth
vs. Year Ago Period: 75.54%
vs. Previous Quarter: 10.13%
ROE
03/31/22 - -187.17
12/31/21 - -163.37
09/30/21 - -152.62
ROA
03/31/22 - -49.57
12/31/21 - -50.91
09/30/21 - -51.66
Current Ratio
03/31/22 - -
12/31/21 - 2.36
09/30/21 - 1.15
Quick Ratio
03/31/22 - -
12/31/21 - 1.51
09/30/21 - 0.77
Operating Margin
03/31/22 - -104.19
12/31/21 - -122.44
09/30/21 - -131.19
Net Margin
03/31/22 - -104.19
12/31/21 - -122.44
09/30/21 - -131.19
Pre-Tax Margin
03/31/22 - -
12/31/21 - -127.82
09/30/21 - -135.37
Book Value
03/31/22 - -
12/31/21 - 0.29
09/30/21 - 0.52
Inventory Turnover
03/31/22 - -
12/31/21 - 1.05
09/30/21 - 0.91
Debt-to-Equity
03/31/22 - -
12/31/21 - 2.72
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - 73.13
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©